Orasure Technologies (OSUR) Non-Current Assets (2010 - 2025)
Orasure Technologies (OSUR) posted Non-Current Assets of $141.3 million for Q4 2025, up 0.84% sequentially from $140.1 million in Q3 2025, and down 3.54% YoY from $146.4 million in Q4 2024.
Orasure Technologies (OSUR) Non-Current Assets (2010 - 2025) Analysis & Trends
Orasure Technologies has reported Non-Current Assets for 16 years, with the latest figure at $141.3 million in Q4 2025.
- Quarterly Non-Current Assets fell 3.54% year-over-year to $141.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $141.3 million (down 3.54% YoY) and the FY2025 annual result came in at $141.3 million, down 3.54% from the prior year.
- Non-Current Assets grew to $141.3 million in Q4 2025 per OSUR's latest filing, from $140.1 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $180.0 million in Q2 2021 and troughed at $96.4 million in Q4 2023.
- A 5-year average of $138.1 million and a median of $142.4 million in 2025 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2021 and 2023: Non-Current Assets jumped 74.99% in 2021, then slumped 33.13% in 2023.
- Over 5 years, Non-Current Assets stood at $161.7 million in 2021, then slipped by 26.41% to $119.0 million in 2022, then decreased by 19.0% to $96.4 million in 2023, then soared by 51.93% to $146.4 million in 2024, then decreased by 3.54% to $141.3 million in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods registered $141.3 million, $140.1 million, and $143.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Orasure Technologies | 274.50 Mn | 75.22 Mn | - | 141.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 141.26 Mn |
| Sep 30, 2025 | 140.09 Mn |
| Jun 30, 2025 | 143.60 Mn |
| Mar 31, 2025 | 143.83 Mn |
| Dec 31, 2024 | 146.44 Mn |
| Sep 30, 2024 | 113.93 Mn |
| Jun 30, 2024 | 115.28 Mn |
| Mar 31, 2024 | 119.05 Mn |
| Dec 31, 2023 | 96.39 Mn |
| Sep 30, 2023 | 101.97 Mn |
| Jun 30, 2023 | 112.03 Mn |
| Mar 31, 2023 | 115.82 Mn |
| Dec 31, 2022 | 118.99 Mn |
| Sep 30, 2022 | 152.48 Mn |
| Jun 30, 2022 | 161.95 Mn |
| Mar 31, 2022 | 167.17 Mn |
| Dec 31, 2021 | 161.68 Mn |
| Sep 30, 2021 | 166.53 Mn |
| Jun 30, 2021 | 180.00 Mn |
| Mar 31, 2021 | 164.09 Mn |